Evidence map›Paper›PMID 22610447›Full record

ReviewMolecular bioSystems2012

The spectral networks paradigm in high throughput mass spectrometry.

Adrian Guthals, Jeramie D Watrous, Pieter C Dorrestein, Nuno Bandeira

Open access · greenAbstract readReview
In one paragraph

Review in Molecular bioSystems, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 91 citations in OpenAlex.

  1. Multiple Spectrum Alignment for Molecular Networking Exploration and Discovery.Journal of the American Society for Mass Spectrometry · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Network Topology Evaluation and Transitive Alignments for Molecular Networking.Journal of the American Society for Mass Spectrometry · 2024
    Article
  6. Article
  7. Article
  8. Review
  9. Cytotoxic Indolocarbazoles From a Marine-DerivedFrontiers in microbiology · 2022
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Screening Immunoactive Compounds ofFrontiers in pharmacology · 2020
    Article
  16. Alphabet Projection of Spectra.Journal of proteome research · 2019
    Article
  17. Review
  18. Article
  19. Toward a global picture of bacterial secondary metabolism.Journal of industrial microbiology & biotechnology · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Adrian GuthalsDept. Computer Science and Engineering, University of California, San Diego, USA.
Jeramie D Watrous
Pieter C Dorrestein
Nuno Bandeira
University of California San Diego · USUniversity of San Diego · US

Funding

TrainingP41GM103484 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PEVZNER, PAVEL A · 2012 to 2018
$8.7M
CENTER FOR COMPUTATIONAL MASS-SPECTROMETRYP41RR024851 · NCRR · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PEVZNER, PAVEL A · 2008 to 2011
$5.2M
The chemical and genetic basis of interspecies interactionsR01AI095125 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DORRESTEIN, PIETER C, POGLIANO, KIT J · 2011 to 2014
$2.4M
Experiment based genome mining of ribosomal natural productsR01GM097509 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DORRESTEIN, PIETER C, MOORE, BRADLEY S · 2012 to 2015
$1.9M
Real-Time Imaging of metabolic CommunicationR01GM094802 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DORRESTEIN, PIETER C · 2010 to 2013
$1.0M
New approaches to sequencing of complex peptides.R01GM086283 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DORRESTEIN, PIETER C, PEVZNER, PAVEL A · 2008 to 2010
$984k
NCRR NIH HHS 1-P41-RR024851NCRR NIH HHS P41 RR024851NIAID NIH HHS AI095125NIAID NIH HHS R01 AI095125NIGMS NIH HHS GM086283NIGMS NIH HHS GM094802NIGMS NIH HHS GM097509NIGMS NIH HHS P41 GM103484NIGMS NIH HHS R01 GM086283NIGMS NIH HHS R01 GM094802NIGMS NIH HHS R01 GM097509
6 · The paper itself

Abstract

High-throughput proteomics is made possible by a combination of modern mass spectrometry instruments capable of generating many millions of tandem mass (MS(2)) spectra on a daily basis and the increasingly sophisticated associated software for their automated identification. Despite the growing accumulation of collections of identified spectra and the regular generation of MS(2) data from related peptides, the mainstream approach for peptide identification is still the nearly two decades old approach of matching one MS(2) spectrum at a time against a database of protein sequences. Moreover, database search tools overwhelmingly continue to require that users guess in advance a small set of 4-6 post-translational modifications that may be present in their data in order to avoid incurring substantial false positive and negative rates. The spectral networks paradigm for analysis of MS(2) spectra differs from the mainstream database search paradigm in three fundamental ways. First, spectral networks are based on matching spectra against other spectra instead of against protein sequences. Second, spectral networks find spectra from related peptides even before considering their possible identifications. Third, spectral networks determine consensus identifications from sets of spectra from related peptides instead of separately attempting to identify one spectrum at a time. Even though spectral networks algorithms are still in their infancy, they have already delivered the longest and most accurate de novo sequences to date, revealed a new route for the discovery of unexpected post-translational modifications and highly-modified peptides, enabled automated sequencing of cyclic non-ribosomal peptides with unknown amino acids and are now defining a novel approach for mapping the entire molecular output of biological systems that is suitable for analysis with tandem mass spectrometry. Here we review the current state of spectral networks algorithms and discuss possible future directions for automated interpretation of spectra from any class of molecules.

Indexed as

SoftwareAlgorithmsAmino Acid SequenceAutomation, LaboratoryBacillus subtilisCataractDatabases, ProteinHumansLens, CrystallineMolecular Sequence DataOligonucleotidesPeptides, CyclicProtein Processing, Post-TranslationalProteomicsTandem Mass SpectrometryOligonucleotidesPeptides, Cyclic

Identifiers

PMID22610447
PMCPMC3893064
OpenAlexW2052877141

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.